Tokyo Tape
Sign in
← Hisamitsu Pharmaceutical Co

Quarterly report · Q1

4530.TEDINET S100U1JX
Period2024-03-01 → 2024-05-31
Filed2024-07-12
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥35.8bn2024-03-01 → 2024-05-31Cons.Net sales
Revenue¥141.7bn2023-03-01 → 2024-02-29Cons.Net sales (5-year summary)
Revenue¥32.1bn2023-03-01 → 2023-05-31Cons.Net sales
Operating income¥4.1bn2024-03-01 → 2024-05-31Cons.Operating income
Operating income¥4.4bn2023-03-01 → 2023-05-31Cons.Operating income
Ordinary income¥5.6bn2024-03-01 → 2024-05-31Cons.Ordinary income
Ordinary income¥19.6bn2023-03-01 → 2024-02-29Cons.Ordinary income loss (5-year summary)
Ordinary income¥5.7bn2023-03-01 → 2023-05-31Cons.Ordinary income
Profit before tax¥6.9bn2024-03-01 → 2024-05-31Cons.Income before income taxes
Profit before tax¥5.7bn2023-03-01 → 2023-05-31Cons.Income before income taxes
Net income (owners)¥4.8bn2024-03-01 → 2024-05-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥14.0bn2023-03-01 → 2024-02-29Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥4.0bn2023-03-01 → 2023-05-31Cons.Profit loss attributable to owners of parent
Net income¥5.0bn2024-03-01 → 2024-05-31Cons.Profit loss
Net income¥4.2bn2023-03-01 → 2023-05-31Cons.Profit loss
Total assets¥338.8bnat 2024-05-31Cons.Assets
Total assets¥328.8bnat 2024-02-29Cons.Assets
Total assets¥320.2bnat 2023-05-31Cons.Total assets (5-year summary)
Total liabilities¥72.0bnat 2024-05-31Cons.Liabilities
Total liabilities¥61.7bnat 2024-02-29Cons.Liabilities
Net assets / equity¥266.9bnat 2024-05-31Cons.Net assets
Net assets / equity¥267.1bnat 2024-02-29Cons.Net assets
Net assets / equity¥261.6bnat 2023-05-31Cons.Net assets (5-year summary)
Cash and deposits¥112.3bnat 2024-05-31Cons.Cash and deposits
Cash and deposits¥112.5bnat 2024-02-29Cons.Cash and deposits
EPS (basic)¥63.892024-03-01 → 2024-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥181.622023-03-01 → 2024-02-29Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥52.092023-03-01 → 2023-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥63.822024-03-01 → 2024-05-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥181.422023-03-01 → 2024-02-29Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥52.052023-03-01 → 2023-05-31Cons.Diluted earnings per share (5-year summary)
Equity ratio78.0%at 2024-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio80.5%at 2024-02-29Cons.Equity to asset ratio (5-year summary)
Equity ratio80.9%at 2023-05-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 316
ItemContextValueUnit
Profit lossCurrentYTDDuration4971000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration129000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration182000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration4049000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration4788000000JPY
Profit lossPrior1YTDDuration4179000000JPY
Profit lossCurrentYTDDuration4971000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration1391000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration1209000000JPY
Foreign currency translation adjustment net of tax ociPrior1YTDDuration995000000JPY
Foreign currency translation adjustment net of tax ociCurrentYTDDuration5919000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration-46000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration-78000000JPY
Share of other comprehensive income of associates accounted for using equity method ociPrior1YTDDuration-17000000JPY
Share of other comprehensive income of associates accounted for using equity method ociCurrentYTDDuration3000000JPY
Other comprehensive incomePrior1YTDDuration2322000000JPY
Other comprehensive incomeCurrentYTDDuration7054000000JPY
Comprehensive incomePrior1YTDDuration6501000000JPY
Comprehensive incomeCurrentYTDDuration12025000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration6320000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration11815000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration181000000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration209000000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の４の７第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2024-07-12
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第123期第１四半期(自 2024年３月１日 至 2024年５月31日)
Company name cover pageFilingDateInstant
Original text (Japanese)久光製薬株式会社
Company name in english cover pageFilingDateInstantHISAMITSU PHARMACEUTICAL CO.,INC.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長 　　中　冨　一　榮
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)佐賀県鳥栖市田代大官町408番地
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)0942(83)2101(代表)
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)執行役員BU本部長　　舛　屋　泰　之
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都千代田区丸の内二丁目４番１号
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)03(5293)1700(代表)
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)執行役員経営企画本部長　　磯　部　雄　一
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE00944
Fund codeFilingDateInstant－
Security codeFilingDateInstant45300
Filer name in japaneseFilingDateInstant
Original text (Japanese)久光製薬株式会社
Filer name in englishFilingDateInstantHisamitsu Pharmaceutical Co.,Inc.
Fund name in japaneseFilingDateInstant－
Fund name in englishFilingDateInstant－
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令
Document typeFilingDateInstant
Original text (Japanese)第四号の三様式
Accounting standardsFilingDateInstantJapan GAAP
Whether consolidated financial statements are preparedFilingDateInstanttrue
Industry code when consolidated financial statements are prepared in accordance with industry specific regulationsFilingDateInstantcte

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2024-02-29pass rounding
balance sheet identityconsolidated 2024-05-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-02-29pass
statement vs summary · net assetsconsolidated 2024-05-31pass
statement vs summary · net income attributable to parentconsolidated 2023-03-01/2023-05-31pass
statement vs summary · net income attributable to parentconsolidated 2024-03-01/2024-05-31pass
statement vs summary · revenueconsolidated 2023-03-01/2023-05-31pass
statement vs summary · revenueconsolidated 2024-03-01/2024-05-31pass
statement vs summary · total assetsconsolidated 2024-02-29pass
statement vs summary · total assetsconsolidated 2024-05-31pass